BeiGene, Ltd.
ONC
$230.98
$2.841.25%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 84.84% | 41.17% | 56.09% | 67.85% | 69.18% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 84.84% | 41.17% | 56.09% | 67.85% | 69.18% |
| Cost of Revenue | 54.59% | 106.01% | 43.90% | 52.75% | 109.98% |
| Gross Profit | 91.21% | 32.78% | 58.44% | 71.23% | -64.62% |
| SG&A Expenses | 31.39% | 34.08% | 12.33% | 30.12% | 22.61% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -105.26% | 105.48% | -- | -- | -- |
| Total Operating Expenses | 23.34% | 38.88% | 13.39% | 23.68% | 20.59% |
| Operating Income | 80.34% | -24.37% | 66.38% | 29.60% | 18.74% |
| Income Before Tax | 79.52% | -162.46% | 71.18% | 27.75% | 25.64% |
| Income Tax Expenses | 417.66% | 8.87% | 5.93% | -32.79% | -0.44% |
| Earnings from Continuing Operations | 58.27% | -175.63% | 68.41% | 27.92% | 24.82% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 58.27% | -175.63% | 68.41% | 27.92% | 24.82% |
| EBIT | 80.34% | -24.37% | 66.38% | 29.60% | 18.74% |
| EBITDA | 90.73% | -26.98% | 71.94% | 32.61% | 20.67% |
| EPS Basic | 59.13% | -175.81% | 68.43% | 27.99% | 25.05% |
| Normalized Basic EPS | 90.82% | -157.98% | 71.40% | 28.48% | -60.14% |
| EPS Diluted | 59.13% | -175.81% | 68.43% | 27.99% | 26.12% |
| Normalized Diluted EPS | 90.82% | -157.98% | 71.40% | 28.48% | -60.14% |
| Average Basic Shares Outstanding | 2.10% | -0.23% | 0.06% | 0.10% | 0.30% |
| Average Diluted Shares Outstanding | 2.10% | -0.23% | 0.06% | 0.10% | 0.30% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -2.23% | -- | -- | -- |